Physician profile
Jack I Newcomer
NPI 1750498259
$2,700.69
in general payments reported to CMS, 2019-2025
16 companies · $475 in 2025
The $475 reported for 2025 was more than what 82% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $229 · 2021: $399 · 2022: $398 · 2023: $435 · 2024: $269 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173 · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.60 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,425.77 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $635.03 | 2019-2025 | Trelegy Ellipta |
| Novo Nordisk INC | $111.20 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $76.85 | 2022-2024 | Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $70.72 | 2020-2022 | |
| Abbvie INC. | $64.55 | 2021-2022 | |
| Lilly USA, LLC | $50.05 | 2021-2023 | Jardiance |
| Allergan, INC. | $48.14 | 2019 | |
| Merz North America, INC. | $43.92 | 2019 | |
| Amarin Pharma, INC. | $38.03 | 2019 | |
| Boston Scientific Corporation | $28.57 | 2025 | Ams 700 |
| Pfizer INC. | $27.74 | 2024 | |
| Eisai INC. | $27.08 | 2025 | |
| Arbor Pharmaceuticals, INC. | $24.67 | 2021 | |
| Idorsia Pharmaceuticals US INC | $15.87 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Newcomer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.